By Matt Skoufalos
Innovatus Imaging of Pittsburgh, Pennsylvania has promoted Tracy Schrecengost to VP of Radiography and Managing Director of European Operations. Schrecengost spent two years in field service operations at Innovatus, in supply chain operations positions for Bayer Healthcare and for Medrad, acquired by Bayer in 2006.
Diversey of Charlotte, North Carolina has named Mark S. Burgess its new CEO, effective December 17, 2018. Burgess succeeds Dr. Ilham Kadri, who is leaving Diversey at the end of the year. Joint interim deputy CEOs Carlos Sagasta and Gaetano Redaelli will return to their respective roles as CFO and Global President, Professional Division. Burgess was previously CEO of Signode Industrial Group, which was acquired by Crown Holdings, Inc. in April 2018. Prior to that role, he was CEO of Graham Packaging Company; he has also been CEO and CFO of Anchor Glass Container Corporation. Burgess holds a Duke University MBA.
The Washington, D.C. Center for Innovative GYN Care has added Abayomi Walker as a nurse practitioner in its Rockville, Maryland CIGC practice. Walker
is a board-certified nurse practitioner specializing in women’s health. She has more than 10 years of experience in gynecology, obstetrics, and maternal child health, including as a minimally invasive GYN surgery nurse practitioner at the George Washington Medical Faculty Associates in Washington DC. Walker holds a master’s degree in nursing from the University of Pennsylvania School of Nursing.
Common Sensing of Cambridge, Massachusetts has named Kevin Schmid its CEO and co-founder James White as chairman of the board. Schmid has previously worked at Insulet Corporation, Bose Corporation, JDS Uniphase, the Stevanato Group, and the board of directors of Sorrel Medical Ltd. Schmid has been a member of the Common Sensing board of directors since November 2015 and its COO since January 2018.
The Anchorage-based Alaska Heart & Vascular Institute has added Carson S. Webb, M.D. to the Mat-Su clinic in Palmer, Alaska. Webb specializes in percutaneous coronary, peripheral arterial, and peripheral venous interventions.
He’s board-certified in interventional, general, and nuclear cardiology as well as internal medicine, and previously spent ten years at Fairbanks Memorial Hospital.
The Focused Ultrasound Foundation of Charlottesville, Virginia has added Syaru Shirley Lin to its board of directors. Lin was previously a partner at Goldman Sachs, and currently serves on the boards of Goldman Sachs Asia Bank, Langham Hospitality Investments and Mercuries Life Insurance. She is on the Hong Kong Committee for Pacific Economic Cooperation, and is an adviser to Crestview Partners.
ValueHealth of Leawood, Kansas has named Rod Carbonell president of its subsidiary Muve Health. Carbonell spent 21 years in hospitals, ASCs, and physician clinics before joining ValueHealth, including as VP for the central and west Texas division of HCA physician services group. Carbonell also held business and clinical operations roles with HCA in Louisiana, Mississippi, Kansas, and Missouri. He began his healthcare career as a registered nurse.
Bayer of Whippany, New Jersey named Albert J. Mitchell VP of corporate engagement in the U.S. and Michael Parrish VP of government relations.
Both joined the company from top leadership positions within Monsanto: Mitchell was named president of Monsanto Fund in March 2016; Parrish most recently was its VP of Public and Industry Affairs for North America.
Smith Seckman Reid, Inc. of Nashville, Tennessee has acquired Atlanta-based medical equipment planning firm Strategic Hospital Resources, the former CEO of which, Debbie Heitzman, will remain, leading its Atlanta office.
Berkshire Sterile Manufacturing of Lee, Massachusetts has named Debbie Smith its VP of Quality Assurance. Smith has 14 years of experience in the pharmaceutical and biotechnology industries, including 12 at Pfizer as a safety representative and safety auditor.
CareDox of New York, New York has named Howard Morgan to its board of directors. A former founding partner of First Round Capital, his appointment brings the company’s board of directors to six members.
Palo Alto Health Sciences of Kirkland, Washington has named Christopher S. Lento as Chief Commercial Officer. Lento has 26 years in the pharmaceutical, biotechnology, medical device, and healthcare technology sectors. He most recently worked with Pear Therapeutics as VP of commercial operations.
The Denver, Colorado-based Vivos Therapeutics has added Brad Amman as CFO. Amman has 20 years in the industry, including at CereScan and LifeVantage. Most recently, he was CFO/COO at InLight Medical. Amman has an MBA from the University of Notre Dame.
Marker Therapeutics of Houston, Texas has named Anthony H. Kim its CFO, replacing Michael J. Loiacono, who will become its Chief Accounting Officer. Kim was most recently executive director in the Healthcare Group at Nomura Securities International, has been SVP in the healthcare group at Jefferies, and an investment banker at Oppenheimer & Co. and J.P. Morgan Securities. Kim holds an MBA with a concentration in finance from the UCLA Anderson School of Management.
Hill-Rom Holdings of Chicago, Illinois, Inc. has named Barbara W. Bodem its SVP and CFO. Bodem joins Hill-Rom from Mallinckrodt, where she was SVP of finance; she succeeds Steven J. Strobel, who will retire. SVP of corporate development and strategy and chief transformation officer Andreas Frank has been appointed SVP and president of the Hill-Rom Front Line Care business, which includes Welch Allyn, Vision Care, and Respiratory Care, replacing Alton Shader. VP of investor relations
Mary Kay Ladone has been named SVP of corporate development, strategy and investor Relations.